NR2E3 and retinitis pigmentosa 1: To this end, the transcription factor NRL and orphan nuclear receptor NR2E3 transcription factors are the subject of extensive investigation in photoreceptor transcriptional regulation [20,44,45] and represent a novel mutation-agnostic therapeutic strategy for RP treatment.